EurekAlert! National Institutes of Health

Latest news releases from NIH-funded organizations

Funded Research News

Updates every hour. Last Updated: 24-Jan-2026 03:11 ET (24-Jan-2026 08:11 GMT/UTC)

10-Nov-2025

Long-term poverty and rising unsecured debt in early adulthood each linked to higher risk of premature death

Columbia University's Mailman School of Public Health
Peer-Reviewed Publication

Adults who experience poverty-level family income—whether sustained or intermittent—over two decades spanning young to mid-adulthood face a significantly higher risk of dying prematurely than those who are never in poverty, according to new research led by Columbia University Mailman School of Public Health

Funder: NIH/National Institute on Aging

10-Nov-2025

Discovery reveals why Alzheimer’s patients forget family, friends

University of Virginia Health System
Peer-Reviewed Publication

One of the most devastating moments for family members of a patient with Alzheimer’s is when their loved one forgets who they are. New findings may explain why that happens and could lead to a way to prevent it.

Funder: NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, Owens Family Foundation

10-Nov-2025

WVU research finds self-control runs in the family

West Virginia University

When it comes to self-control, adolescents tend to follow the patterns their parents establish, according to West Virginia University psychology researcher Amy Gentzler who led a six-month survey of more than 200 Appalachian adolescents and their parents.

Journal: Social Development
Funder: NIH/National Institutes of Health

10-Nov-2025

Obesity drugs improve heart health: Study shows additional benefits of semaglutide and tirzepatide

Technical University of Munich (TUM)
Peer-Reviewed Publication

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School have demonstrated this in using insurance claims data. They found that semaglutide and tirzepatide – marketed as Ozempic and Mounjaro – reduced the risk of serious cardiovascular events by up to 18 percent.

Journal: Nature Medicine
Funder: NIH/National Institutes of Health, Deutsche Herzstiftung
Meeting: American Heart Association Scientific Sessions 2025

10-Nov-2025

GLP-1 drugs tirzepatide and semaglutide provide protection for heart health

Mass General Brigham
Peer-Reviewed Publication

Mass General Brigham researchers used real-world data to conduct a head-to-head study to investigate cardioprotective effects, finding both medications reduced risk

Journal: Nature Medicine
Funder: NIH/National Institutes of Health, NIH/National Institutes of Health, German Heart Foundation